REPORT ID 17947

Global Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2022

Publish Date
03-Oct-17
Pages
106
Format
Electronic (PDF)

This report studies the global Chronic Idiopathic Constipation Drugs market, analyzes and researches the Chronic Idiopathic Constipation Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Pfizer
    Glaxosmithkline
    Roche Holding AG
    Sanofi
    Bayer AG
    Merck
    Eli Lilly
    Allergens
    Chugai Pharmaceutical
    Ferring International Center S.A
    Synergy Pharmaceuticals
    Salix Pharmaceuticals Ltd
    Sucampo Pharmaceuticals Inc
    Ironwood Pharmaceuticals Inc
    Valeant Pharmaceuticals International
    Daiichi Sankyo
    Cosmo Pharmaceuticals SA
    Progenics Pharmaceuticals Inc
    Theravance Biopharma Inc

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Chronic Idiopathic Constipation Drugs can be split into
    Linaclotide
    Lubiprostone
    Other

Market segment by Application, Chronic Idiopathic Constipation Drugs can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Chronic Idiopathic Constipation Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Chronic Idiopathic Constipation Drugs
    1.1  Chronic Idiopathic Constipation Drugs Market Overview
        1.1.1 Chronic Idiopathic Constipation Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Chronic Idiopathic Constipation Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Chronic Idiopathic Constipation Drugs Market by Type
        1.3.1 Linaclotide
        1.3.2 Lubiprostone
        1.3.3 Other
    1.4 Chronic Idiopathic Constipation Drugs Market by End Users/Application
        1.4.1 Hospital Pharmacies
        1.4.2 Retail Pharmacies
        1.4.3 Online Pharmacies

2 Global Chronic Idiopathic Constipation Drugs Competition Analysis by Players
    2.1 Chronic Idiopathic Constipation Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Pfizer
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Glaxosmithkline
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Roche Holding AG
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Sanofi
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Bayer AG
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Merck
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Eli Lilly
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Allergens
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Chugai Pharmaceutical
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Ferring International Center S.A
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Chronic Idiopathic Constipation Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Synergy Pharmaceuticals
    3.12 Salix Pharmaceuticals Ltd
    3.13 Sucampo Pharmaceuticals Inc
    3.14 Ironwood Pharmaceuticals Inc
    3.15 Valeant Pharmaceuticals International
    3.16 Daiichi Sankyo
    3.17 Cosmo Pharmaceuticals SA
    3.18 Progenics Pharmaceuticals Inc
    3.19 Theravance Biopharma Inc

4 Global Chronic Idiopathic Constipation Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Chronic Idiopathic Constipation Drugs Market Size by Type (2012-2017)
    4.2 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Chronic Idiopathic Constipation Drugs in Future
    4.4 Top Consumer/End Users of Chronic Idiopathic Constipation Drugs

5 United States Chronic Idiopathic Constipation Drugs Development Status and Outlook
    5.1 United States Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    5.2 United States Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Chronic Idiopathic Constipation Drugs Development Status and Outlook
    6.1 EU Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    6.2 EU Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Chronic Idiopathic Constipation Drugs Development Status and Outlook
    7.1 Japan Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    7.2 Japan Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Chronic Idiopathic Constipation Drugs Development Status and Outlook
    8.1 China Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    8.2 China Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Chronic Idiopathic Constipation Drugs Development Status and Outlook
    9.1 India Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    9.2 India Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Chronic Idiopathic Constipation Drugs Development Status and Outlook
    10.1 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size (2012-2017)
    10.2 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Chronic Idiopathic Constipation Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Chronic Idiopathic Constipation Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Chronic Idiopathic Constipation Drugs Market Size by Application (2017-2022)

12 Chronic Idiopathic Constipation Drugs Market Dynamics
    12.1 Chronic Idiopathic Constipation Drugs Market Opportunities
    12.2 Chronic Idiopathic Constipation Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Chronic Idiopathic Constipation Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Chronic Idiopathic Constipation Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source